Fundai

Darou Pakhsh Pharmaceutical Distribution Company (DTOZI) income statement

Operating revenue through to net profit and earnings per share

Ticker
DTOZI
Industry
Pharmaceuticals
Market
Iran Fara Bourse

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Operating revenue484,137,575187,222,250125,942,18088,323,02558,036,16646,135,496
Cost of operating revenue-436,547,848-168,571,645-113,522,301-79,418,957-49,927,168-40,926,502
Gross profit (loss)47,589,72718,650,60512,419,8798,904,0688,108,9985,208,994
Selling, general and administrative expenses-13,205,890-8,862,210-6,382,226-4,661,778-3,143,591-1,917,295
Other income4,9812,3376,007001,151
Other expenses-15,104-5,1970-2,924-2020
Operating profit (loss)34,373,7149,785,5356,043,6604,239,3664,965,2053,292,850
Finance costs-5,083,835-1,706,327-2,293,556-2,210,281-849,620-545,769
Other non-operating income and expenses433,546272,958319,181300,07264,342114,644
Profit (loss) from continuing operations before tax29,723,4258,352,1664,069,2852,329,1574,179,9272,861,725
Current year tax-6,964,349-1,923,599-1,024,596-482,751-988,383-656,688
Net profit (loss) from continuing operations22,759,0766,428,5673,044,6891,846,4063,191,5442,205,037
Net profit (loss)22,759,0766,428,5673,044,6891,846,4063,191,5442,205,037
Basic earnings (loss) per share759 rials214 rials1,691 rials1,026 rials1,809 rials2,382 rials
Net earnings (loss) per share, rials759 rials215 rials1,692 rials1,026 rials2,660 rials1,838 rials
Capital30,000,00030,000,0001,800,0001,800,0001,200,0001,200,000

Reporting periods

40 periods are on file for this report, from the period ending 1396/12/29 to the period ending 1405/06/31.